← Insider buys
IMVT

Immunovant, Inc. · Healthcare

CTO Jay S Stout sold $81K of Immunovant, Inc.

Sold$80,912
$29.53Price
2,740Shares
−2%Stake

What IMVT did after the filing

Filed Oct 25Copier in Oct 28
The stock from Mon, Oct 28 open, $30.43
−4.9%
S&P 500, same days
+3.5%

Measured over 30 trading days, to the Dec 10 close.

Traded Wed, Oct 23. Filed Fri, Oct 25, 4:21 PM ET, after the close. Returns use the Oct 28 open and the Dec 10 close. Not investment advice.